2011-06-17 Assigned to IMMUNOGEN, INC. reassignment IMMUNOGEN, INC.
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …

US8709432B2 - Methods for increasing efficacy of FOLR1 cancer therapy - Google Patents
US8709432B2 - Methods for increasing efficacy of FOLR1 cancer therapy - Google Patents …

(*) Notice: Subject to any disclaimer, the term of this 2006/01 10771 A1 5/2006 kA. al. patent
is extended or adjusted under 35 2006/0228349 A1 10, 2006 Acton et al. USC 154 (b) by …

2018-04-10 Assigned to TRON-TRANSLATIONALE ONKOLOGIE AN DER
UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ …

Related US Application Data (60) Continuation of application No. 14/819.209, filed on Aug.
5, 2015, which is a division of application No. 13/800,835, filed on Mar. 13, 2013, now Pat …

US9200073B2 - Diagnostic assays and kits for detection of folate receptor 1 - Google Patents
US9200073B2 - Diagnostic assays and kits for detection of folate receptor 1 - Google Patents …

2015-11-13 Assigned to IMMUNOGEN, INC. reassignment IMMUNOGEN, INC.
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …

2016-09-30 Assigned to IMMUNOGEN, INC. reassignment IMMUNOGEN, INC.
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …

The present invention provides antibodies useful as therapeu tics for treating and/or
preventing diseases associated with cells expressing CLDN6, including tumor-related …

4, 371, 533 A 4, 424, 219 A 4, 450, 254 A 5, 208, 020 A 5, 416, 016 A 5, 416, 064 A 5, 475,
092 A 5, 585, 499 A 5, 720, 954 A 5, 846, 545 A 5, 855, 866 A 6, 051, 230 A 6, 054, 297 A 6 …